| Medical Condition | Asthma |
| Facility/Clinic | Accellacare – 1222 Medical Center Dr |
| Age | 12+ |
| Gender | Male & Female |
| Description | A study comparing a new biologic medication to the standard of care, mepolizumab or benralizumab to treat severe asthma. |
| Enrollment | Open |
| Patient Commitment Duration | 66 weeks |
| Number of visits in study | 18 |
| Patient Compensation | $150/visit |
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.